StockData
Novo Nordisk A S logo

Novo Nordisk A S

NVONYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NONOF
Financials through fiscal 2025, year ended Dec 31, 2025Score 4/30
$37.82−1.05 (-2.70%)

Close on Nov 20, 2026Market cap $168.87BP/E 11.1Yield –

Novo Nordisk A S Parent Company — Cost of goods sold (DKKm) by Year

Novo Nordisk A S Parent Company — Cost of goods sold (DKKm): 73,168.00 DKKm in FY2025, up 49.5% from a year earlier.

Latest, FY2025
73,168.00
Period ended Dec 31, 2025
Change on a year earlier
+49.5%
48,930.00 in FY2024
History
7 years
Since FY2019
Sources
6
Documents cited below

Where the FY2025 figure comes from

“|| Cost of goods sold | 3 | (73,168) | (48,930)”

Source: Form 20-F (filed 2026-02-04) ↗

annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedParent Company — Cost of goods sold (DKKm)Year on yearSource
FY2025Dec 31, 202573,168.00+49.5%Form 20-F (filed 2026-02-04) ↗
FY2024Dec 31, 202448,930.00+27.3%Form 20-F (filed 2026-02-04) ↗
FY2023Dec 31, 202338,433.00+23.7%Form 20-F (filed 2025-02-05) ↗
FY2022Dec 31, 202231,060.00+16.6%Form 20-F (filed 2024-01-31) ↗
FY2021Dec 31, 202126,642.00+28.9%Form 20-F (filed 2023-02-01) ↗
FY2020Dec 31, 202020,662.00+15.2%Form 20-F (filed 2022-02-02) ↗
FY2019Dec 31, 201917,940.00–Form 6-K (filed 2021-02-03) ↗

Cite this data

StockData. (2026). Novo Nordisk A S Parent Company — Cost of goods sold (DKKm), annual FY2019–FY2025 [Data set]. Compiled from Novo Nordisk A S SEC filings and investor materials. https://stockdatahq.com/stocks/nvo/kpis/parent-cogs

See every metric in the Novo Nordisk A S KPI table. Data updated Nov 3, 2026.

See a number that looks wrong?